| 000 | 01886 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250515005601.0 | ||
| 264 | 0 | _c20060221 | |
| 008 | 200602s 0 0 eng d | ||
| 022 | _a1524-4539 | ||
| 024 | 7 |
_a10.1161/CIRCULATIONAHA.105.565556 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStraczek, Céline | |
| 245 | 0 | 0 |
_aProthrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration. _h[electronic resource] |
| 260 |
_bCirculation _cNov 2005 |
||
| 300 |
_a3495-500 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aDrug Administration Routes |
| 650 | 0 | 4 |
_aEstrogens _xadministration & dosage |
| 650 | 0 | 4 | _aFactor V |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHormone Replacement Therapy _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aMutation, Missense |
| 650 | 0 | 4 |
_aPostmenopause _xphysiology |
| 650 | 0 | 4 |
_aProthrombin _xgenetics |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aThromboembolism _xepidemiology |
| 650 | 0 | 4 |
_aThrombophilia _xgenetics |
| 650 | 0 | 4 |
_aVenous Thrombosis _xepidemiology |
| 700 | 1 | _aOger, Emmanuel | |
| 700 | 1 | _aYon de Jonage-Canonico, Marianne Beau | |
| 700 | 1 | _aPlu-Bureau, Geneviève | |
| 700 | 1 | _aConard, Jacqueline | |
| 700 | 1 | _aMeyer, Guy | |
| 700 | 1 | _aAlhenc-Gelas, Martine | |
| 700 | 1 | _aLévesque, Hervé | |
| 700 | 1 | _aTrillot, Nathalie | |
| 700 | 1 | _aBarrellier, Marie-Thérèse | |
| 700 | 1 | _aWahl, Denis | |
| 700 | 1 | _aEmmerich, Joseph | |
| 700 | 1 | _aScarabin, Pierre-Yves | |
| 773 | 0 |
_tCirculation _gvol. 112 _gno. 22 _gp. 3495-500 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/CIRCULATIONAHA.105.565556 _zAvailable from publisher's website |
| 999 |
_c15924879 _d15924879 |
||